These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19593945)

  • 1. Outcome of patients with dilated cardiomyopathy in a contemporary Swiss population.
    Vischer A; Osswald S; Sticherling C; Schaer B
    Acta Cardiol; 2009 Jun; 64(3):347-50. PubMed ID: 19593945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?".
    Zecchin M; Merlo M; Pivetta A; Barbati G; Lutman C; Gregori D; Serdoz LV; Bardari S; Magnani S; Di Lenarda A; Proclemer A; Sinagra G
    Am J Cardiol; 2012 Mar; 109(5):729-35. PubMed ID: 22176998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sudden cardiac death in dilated cardiomyopathy -- therapeutic options.
    Grimm W; Maisch B
    Herz; 2002 Dec; 27(8):750-9. PubMed ID: 12574892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of left ventricular function improvement after primary prevention ICD implantation for non-ischaemic dilated cardiomyopathy: a multicentre experience.
    Verma A; Wulffhart Z; Lakkireddy D; Khaykin Y; Kaplan A; Sarak B; Biria M; Pillarisetti J; Bhat P; Di Biase L; Constantini O; Quan K; Natale A
    Heart; 2010 Apr; 96(7):510-5. PubMed ID: 19884110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years.
    Merlo M; Pivetta A; Pinamonti B; Stolfo D; Zecchin M; Barbati G; Di Lenarda A; Sinagra G
    Eur J Heart Fail; 2014 Mar; 16(3):317-24. PubMed ID: 24464640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.
    Kadish A; Dyer A; Daubert JP; Quigg R; Estes NA; Anderson KP; Calkins H; Hoch D; Goldberger J; Shalaby A; Sanders WE; Schaechter A; Levine JH;
    N Engl J Med; 2004 May; 350(21):2151-8. PubMed ID: 15152060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and long-term prognosis in patients with chronic heart failure and reduced ejection fraction in China.
    Liu X; Yu H; Pei J; Chu J; Pu J; Zhang S
    Heart Lung Circ; 2014 Sep; 23(9):818-26. PubMed ID: 24881031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of mortality in patients undergoing cardiac resynchronization therapy: baseline clinical, echocardiographic, and angioscintigraphic evaluation prior to resynchronization.
    de Sisti A; Toussaint JF; Lavergne T; Ollitrault J; Abergel E; Paziaud O; Ait Said M; Sader R; LE Heuzey JY; Guize L
    Pacing Clin Electrophysiol; 2005 Dec; 28(12):1260-70. PubMed ID: 16403157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary Outcome in Patients With Idiopathic Dilated Cardiomyopathy.
    Broch K; Murbræch K; Andreassen AK; Hopp E; Aakhus S; Gullestad L
    Am J Cardiol; 2015 Sep; 116(6):952-9. PubMed ID: 26233575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of different aetiologies on clinical course and outcome in patients with dilated cardiomyopathy.
    Pankuweit S; Lüers C; Richter A; Ruppert V; Gelbrich G; Maisch B;
    Eur J Clin Invest; 2015 Sep; 45(9):906-17. PubMed ID: 26094644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How the natural history of dilated cardiomyopathy has changed. Review of the Registry of Myocardial Diseases of Trieste].
    Di Lenarda A; Pinamonti B; Mestroni L; Salvi A; Sabbadini G; Gregori D; Perkan A; Zecchin M; Carniel E; Bussani R; Silvestri F; Morgera T; Camerini F; Sinagra G
    Ital Heart J Suppl; 2004 Apr; 5(4):253-66. PubMed ID: 15185463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of non-ischemic dilated cardiomyopathy patients with left ventricular ejection fraction ≤19% on medical therapy.
    Agstam S; Bahl A; Kumar RM
    Indian Heart J; 2020; 72(6):557-562. PubMed ID: 33357645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of one-year outcome (death and rehospitalization) in hospitalized heart failure patients with left ventricular ejection fraction >50% versus those with ejection fraction <50%.
    Ezekowitz JA; Lee DS; Tu JV; Newman AM; McAlister FA
    Am J Cardiol; 2008 Jul; 102(1):79-83. PubMed ID: 18572040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials of prophylactic implantable defibrillator therapy in patients with nonischemic cardiomyopathy: what have we learned and what can we expect from future trials?
    Grimm W
    Card Electrophysiol Rev; 2003 Dec; 7(4):463-7. PubMed ID: 15071276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
    Zecchin M; Di Lenarda A; Proclemer A; Faganello G; Facchin D; Petz E; Sinagra G
    Europace; 2004 Sep; 6(5):400-6. PubMed ID: 15294264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in management and outcome of ischemic and non-ischemic cardiomyopathy.
    Ng AC; Sindone AP; Wong HS; Freedman SB
    Int J Cardiol; 2008 Sep; 129(2):198-204. PubMed ID: 17706807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
    Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.